Abstract Library

#4121 The efficacy and safety analysis of transarterial embolisation in the treatment of cystic neuroendocrine neoplasm liver metastasis

Introduction: Liver metastases are common in neuroendocrine neoplasm (NEN). Cystic NEN liver metastases (cNENLM) are rare, and the efficacy of transarterial embolization (TAE) has not been reported.

Conference:

Presenting Author:

Authors: Yu H, Wang Y, Zhang N, Liu H, Chen L,

Keywords: Transaterial embolization, Neuroendocrine neoplasm, Liver metastasis, Cystic, Efficacy, Safety,

#4052 Transarterial embolisation for liver metastasis in patients with well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors

Introduction: The role of local treatments, including liver-directed transarterial embolization (TAE), in patients (pts) with liver metastasis of advanced grade 3 gastroenteropancreatic neuroendocrine tumor (G3 GEP-NET) is still less understood.

Conference:

Presenting Author: Chen L

Authors: Chen L, Yang D, Yusufu Y, Liu M, Lin Y,

Keywords: gastroenteropancreatic neuroendocrine tumor, transarterial embolization, liver metastasis,

#3956 Comparative efficacy of Surufatinib plus transarterial embolization versus Surufatinib monotherapy in neuroendocrine tumor with liver metastasis: A prospective, randomised, controlled trial

Introduction: Surufatinib (SUR), an oral tyrosine kinase inhibitor, is a standard treatment for advanced NETs. Transarterial embolization (TAE) is a key local treatment for inoperable liver metastases from NETs.

Conference:

Presenting Author:

Authors: Li X, Li R, Cheng K, Cao D,

Keywords: Surufatinib, transarterial embolization, neuroendocrine tumor, liver metastasis,

#3954 Comparison of transarterial embolisation (TAE) or chemoembolisation (TACE) using streptozotocin (STZ) and biomarker study in patients with metastatic neuroendocrine tumors (NET)

Introduction: We compared TACE and TAE in patients with pancreatic (pNET) or small-intestine NET (siNET) and explored the role of biomarkers related to alkylating agents (O6-methylguanine-methyltransferase [MGMT], alkylpurine–DNA–N-glycosylase [APNG]) or hypoxia (Carbonic anhydrase IX [CAIX]).

Conference:

Presenting Author: de Mestier L

Authors: Vedie A, Dioguardii Burgioo M, Matteini F, Akez M, Hentic O,

Keywords: transarterial embolization, chemoembolization, metastatic neuroendocrine tumor, biomarker,

#2786 Outcome of NET Liver Metastases Treated by TAE Using Microspheres

Introduction: Liver metastases are common in patients with neuroendocrine tumors (NETs), which are associated with the prognosis. Transarterial embolization (TAE) is one of the options for selective therapy in patients with multiple unresectable progressive liver metastases after chemotherapy.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Chen X

Authors: Chen X, Hu L,

Keywords: transarterial embolization, neuroendocrine tumors, NETs, microspheres,